|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-10
|
|
pubmed:abstractText |
The presence of lymph node metastasis in esophageal squamous cell carcinoma (ESCC) patients is a critical factor for decision of treatment strategy. However, there have been no molecular markers to assess lymph node metastasis. In this study, we aimed to identify CpG islands (CGIs) whose DNA methylation statuses are associated with the presence of lymph node metastasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
pubmed-author:GyobuKenK,
pubmed-author:IgakiHiroyasuH,
pubmed-author:KushimaRyojiR,
pubmed-author:LeeShigeruS,
pubmed-author:MatsudaYasunoriY,
pubmed-author:NiwaTohruT,
pubmed-author:OkaDaijiD,
pubmed-author:OsugiHarushiH,
pubmed-author:SuehiroShigefumiS,
pubmed-author:UshijimaToshikazuT,
pubmed-author:YamashitaSatoshiS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1185-94
|
|
pubmed:meshHeading |
pubmed-meshheading:21042947-Adult,
pubmed-meshheading:21042947-Aged,
pubmed-meshheading:21042947-Aged, 80 and over,
pubmed-meshheading:21042947-Carcinoma, Squamous Cell,
pubmed-meshheading:21042947-CpG Islands,
pubmed-meshheading:21042947-DNA Methylation,
pubmed-meshheading:21042947-Esophageal Neoplasms,
pubmed-meshheading:21042947-Female,
pubmed-meshheading:21042947-Humans,
pubmed-meshheading:21042947-Lymphatic Metastasis,
pubmed-meshheading:21042947-Male,
pubmed-meshheading:21042947-Middle Aged,
pubmed-meshheading:21042947-Prognosis,
pubmed-meshheading:21042947-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas.
|
|
pubmed:affiliation |
Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|
